Concepedia

Prashant S. Kharkar

PS

41

Publications

1.3K

Citations

22

H-Index

2002

Active since

Affiliations

Narsee Monjee Institute of Management Studies(Current)

Wayne State University

New York University

Institute of Chemical Technology

Piramal (India)

Prashant S. Kharkar is an author at Narsee Monjee Institute of Management Studies specializing in medicine, drug discovery, and pharmacology.

ORCID

Top concepts

Publications per year

2002–2022

41

Publications

41

Three-Dimensional Quantitative Structure−Activity Relationship of 1,4-Dihydropyridines As Antitubercular Agents

Prashant S. Kharkar, Bhavik Desai, Harsukh Gaveria et al. · Journal of Medicinal Chemistry · 2002 · 113 citations

Banana Peel Waste: An Emerging Cellulosic Material to Extract Nanocrystalline Cellulose

Shweta Mishra, Bala Prabhakar, Prashant S. Kharkar et al. · ACS Omega · 2022 · 82 citations · Full text

Interaction of cocaine‐, benztropine‐, and GBR12909‐like compounds with wild‐type and mutant human dopamine transporters: molecular features that differentially determine antagonist‐binding properties

Kyle C. Schmitt, Juan Zhen, Prashant S. Kharkar et al. · Journal of Neurochemistry · 2008 · 74 citations · Full text

Phospholipid complex-loaded self-assembled phytosomal soft nanoparticles: evidence of enhanced solubility, dissolution rate, ex vivo permeability, oral bioavailability, and antioxidant potential of mangiferin

Darshan R. Telange, Nazish K. Sohail, Atul T. Hemke et al. · Drug Delivery and Translational Research · 2020 · 66 citations

, , +8

Development of (<i>S</i>)-<i>N</i><sup>6</sup>-(2-(4-(Isoquinolin-1-yl)piperazin-1-yl)ethyl)-<i>N</i><sup>6</sup>-propyl-4,5,6,7-tetrahydrobenzo[<i>d</i>]-thiazole-2,6-diamine and Its Analogue as a D3 Receptor Preferring Agonist: Potent in Vivo Activity in Parkinson’s Disease Animal Models

Balaram Ghosh, Tamara Antonio, Juan Zhen et al. · Journal of Medicinal Chemistry · 2009 · 62 citations · Full text

Rows per page

1–5 of 41